Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Oncolytics Bio (ONC.TO)

Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks in play: Oncolytics Biotech Inc

Announced that Chief Financial Officer Kirk Look will participate in a fireside chat at the H.C. Wainwright ...

ONC.TO : 1.28 (-1.54%)
Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 0.9300 (-2.99%)
ONC.TO : 1.28 (-1.54%)
Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates

/CNW/ -- USA News Group – Pancreatic cancer is among the deadliest cancers, prompting researchers to focus on early detection to improve survival rates. Johns...

ONCY : 0.9300 (-2.99%)
HALO : 62.31 (+0.61%)
CADL : 7.76 (+10.39%)
MRUS : 49.42 (-1.36%)
RHHBY : 39.6100 (+0.71%)
ONC.TO : 1.28 (-1.54%)
Biotech Innovations Poised to Transform Pancreatic Cancer Treatment and Patient Outcomes

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – Pancreatic cancer is among the...

ONCY : 0.9300 (-2.99%)
ONC.TO : 1.28 (-1.54%)
RHHBY : 39.6100 (+0.71%)
HALO : 62.31 (+0.61%)
CADL : 7.76 (+10.39%)
MRUS : 49.42 (-1.36%)
Stocks in play: Oncolytics Biotech® Inc.

Announced that Chief Medical Officer Dr. Thomas Heineman will participate in a fireside chat at Canaccord ...

ONC.TO : 1.28 (-1.54%)
Stocks in play: Oncolytics Biotech Inc

Today announced that Chief Medical Officer Dr. Thomas Heineman will participate in a fireside chat at ...

ONC.TO : 1.28 (-1.54%)
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 0.9300 (-2.99%)
ONC.TO : 1.28 (-1.54%)
Stocks in play: Oncolytics Biotech Inc.

Today announced that it will host a conference call and webcast on Thursday, August 1, at 4:30 p.m. ...

ONC.TO : 1.28 (-1.54%)
Stocks in play: Oncolytics Biotech Inc

Today announced it will host a conference call and webcast on Thursday, August 1, 2024, at 4:30 p.m. ...

ONC.TO : 1.28 (-1.54%)
Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 0.9300 (-2.99%)
ONC.TO : 1.28 (-1.54%)

Barchart Exclusives

3 Top Dividend Stocks to Buy This September
After today's jumbo rate cut from the Fed, here are three dividend stocks to bolster your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar